Stevanato Group S.p.A (STVN) Cash from Investing Activities Growth (1y) (2021 - 2026)
Stevanato Group S.p.A (STVN) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -528.34% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -4.51% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -4.35% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -82.56% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 40.11% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -13.64% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -420.31% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -104.07% |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | -10.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.81% |
| Dec 31, 2025 | -13.00% |
| Sep 30, 2025 | -7.85% |
| Jun 30, 2025 | 9.76% |
| Mar 31, 2025 | 32.95% |
| Dec 31, 2024 | 2.08% |
| Sep 30, 2024 | 63.70% |
| Jun 30, 2024 | 28.33% |
| Mar 31, 2024 | 10.01% |
| Dec 31, 2023 | -41.27% |
| Sep 30, 2023 | -230.40% |
| Jun 30, 2023 | -28.43% |
| Mar 31, 2023 | -100.96% |
| Dec 31, 2022 | -191.22% |
| Sep 30, 2022 | -28.96% |
| Jun 30, 2022 | -178.23% |
| Mar 31, 2022 | -126.80% |
| Dec 31, 2021 | 36.34% |
| Sep 30, 2021 | -38.90% |